Your browser doesn't support javascript.
loading
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
Zelenetz, Andrew D; Barrientos, Jacqueline C; Brown, Jennifer R; Coiffier, Bertrand; Delgado, Julio; Egyed, Miklós; Ghia, Paolo; Illés, Árpád; Jurczak, Wojciech; Marlton, Paula; Montillo, Marco; Morschhauser, Franck; Pristupa, Alexander S; Robak, Tadeusz; Sharman, Jeff P; Simpson, David; Smolej, Lukás; Tausch, Eugen; Adewoye, Adeboye H; Dreiling, Lyndah K; Kim, Yeonhee; Stilgenbauer, Stephan; Hillmen, Peter.
Afiliação
  • Zelenetz AD; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. Electronic address: zeleneta@mskcc.org.
  • Barrientos JC; Hofstra Northwell School of Medicine, Hofstra University, New Hyde Park, NY, USA.
  • Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Coiffier B; Department of Haematology, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.
  • Delgado J; Department of Haematology, Hospital Clínic, Barcelona, Spain.
  • Egyed M; Department of Haematology, Somogy County Kaposi Mór Hospital, Kaposvar, Hungary.
  • Ghia P; Division of Experimental Oncology and Department of Onco-Haematology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
  • Illés Á; Department of Haematology, University of Debrecen, Debrecen, Hungary.
  • Jurczak W; Department of Haematology, Jagiellonian University, Krakow, Poland.
  • Marlton P; Department of Haematology, Princess Alexandra Hospital, University of Queensland, School of Medicine, Brisbane, Australia.
  • Montillo M; Department of Haematology, Niguarda Cancer Center, Niguarda Hospital, Milan, Italy.
  • Morschhauser F; CHRU Lille, Unité GRITA, Department of Haematology, Université de Lille, Lille, France.
  • Pristupa AS; Department of Haematology, Ryazan Regional Clinical Hospital, Ryazan, Russia.
  • Robak T; Department of Haematology, Medical University of Lodz and Copernicus Memorial Hospital, Lodz, Poland.
  • Sharman JP; US Oncology Research, Willamette Valley Cancer Institute and Research Center, Eugene, OR, USA.
  • Simpson D; North Shore Hospital, Takapuna, Auckland, New Zealand.
  • Smolej L; 4th Department of Internal Medicine-Haematology, University Hospital and Charles University in Prague, Faculty of Medicine in Hradec Králové, Hradec Králové, Czech Republic.
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Adewoye AH; Gilead Sciences, Foster City, CA, USA.
  • Dreiling LK; Gilead Sciences, Foster City, CA, USA.
  • Kim Y; Gilead Sciences, Foster City, CA, USA.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Hillmen P; Department of Haematology/Oncology, St James's University Hospital, Leeds, UK.
Lancet Oncol ; 18(3): 297-311, 2017 03.
Article em En | MEDLINE | ID: mdl-28139405
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article